Garratty G. Drug induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985;2:1-8.Search in Google Scholar
Garratty G. Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1989;5:97-106.10.21307/immunohematology-2019-1075Search in Google Scholar
Garratty G. Immune hemolytic anemia and/or positive direct antiglobulin tests caused by drugs. Immunohematology 1994;10:41-50.10.21307/immunohematology-2019-817Search in Google Scholar
Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone, 1980.Search in Google Scholar
Garratty, G. Drug-induced immune hemolytic anemia. In:Garratty G,ed. Immunobiology of transfusion medicine. New York: Dekker, 1994:523-51.Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004: 261-317.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Garratty G, Arndt P, Leger R. The changing spectrum of drug-induced immune hemolytic anemia over the last 25 years (abstract). Blood 2003;102:560a.Search in Google Scholar
Gralnick HR, McGinniss M, Elton W, et al. Hemolytic anemia associated with cephalothin. JAMA 1971; 217:1193-7.10.1001/jama.1971.03190090015004Search in Google Scholar
Jeannet M, Bloch A, Dayer JM,et al. Cephalothin- induced immune hemolytic anemia. Acta Haematol 1976;55:109-17.10.1159/000208002816141Search in Google Scholar
Rubin RN, Burka ER. Anti-cephalothin antibody and Coombs’-positive hemolytic anemia. Ann Intern Med 1977; 86:64-5.10.7326/0003-4819-86-1-64299995Search in Google Scholar
Moake JL, Butler CF, Hewell GM,et al. Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity. Transfusion 1978;18: 369-73.10.1046/j.1537-2995.1978.18378205151.x96555Search in Google Scholar
Forbes CD, Mitchell R, Craig JA,et al. Acute intravascular haemolysis associated with cephalexin therapy. Postgrad Med J 1972;48:186-8.10.1136/pgmj.48.557.18624952085024157Search in Google Scholar
Manoharan A,Kot T. Cephalexin-induced haemolytic anaemia (letter). Med J Aust 1987;147:202.10.5694/j.1326-5377.1987.tb133379.x3657639Search in Google Scholar
Branch DR, Berkowitz LR, Becker RL, et al. Extravascular hemolysis following the administration of cefamandole. Am J Hematol 1985;18: 213-9.10.1002/ajh.28301802133970014Search in Google Scholar
Toy E, Nesbitt R, Savastano G, et al. Warm autoantibody following plasma apheresis, complicated by acute intravascular hemolysis associated with cefoxitin-dependent antibody resulting in fatality (abstract).Transfusion 1989;29(Suppl): 51S.Search in Google Scholar
DeTorres OH. Hemolytic anemia and pancytopenia induced by cefoxitin. Drug Intell Clin Pharm 1983;17:816-8.10.1177/106002808301701106Search in Google Scholar
Shulman IA, Arndt PA, McGehee W. Cefotaxime- induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism.Transfusion 1990;30:263-6.10.1046/j.1537-2995.1990.30390194351.xSearch in Google Scholar
Salama A, Göttsche B, Schleffer T,et al. ‘Immune complex’ mediated intravascular hemolysis due to IgM cephalosporin dependent antibody. Transfusion 1987;27:460-3.10.1046/j.1537-2995.1987.27688071694.xSearch in Google Scholar
Malaponte G, Arcidiacono C, Mazzarino C,et al. Cephalosporin-induced hemolytic anemia in a Sicilian child. Hematology 2000;5:327-34.10.1080/10245332.2000.11746527Search in Google Scholar
Garratty G, Postoway N, Schwellenbach J,et al. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176-9.10.1046/j.1537-2995.1991.31291142951.xSearch in Google Scholar
Lo G, Higginbottom P. Ceftriaxone induced hemolytic anemia (abstract). Transfusion 1993;33: (Suppl):25S.Search in Google Scholar
Bernini JC, Mustafa MM, Sutor LJ,et al. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia. J Pediatr 1995;126:813-5.10.1016/S0022-3476(95)70417-5Search in Google Scholar
Lascari AD, Amyot K. Fatal hemolysis caused by ceftriaxone. J Pediatr 1995;126:816-7.10.1016/S0022-3476(95)70418-3Search in Google Scholar
Borgna-Pignatti C, Bezzi TM, Reverberi R. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1995;14:1116-7.10.1097/00006454-199512000-00023Search in Google Scholar
Scimeca PG, Weinblatt ME, Boxer R. Hemolysis after treatment with ceftriaxone (letter). J Pediatr 1996;128:163.10.1016/S0022-3476(96)70456-0Search in Google Scholar
Moallem HJ, Garratty G, Wakeham M, et al. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr 1998; 133:279-81.10.1016/S0022-3476(98)70236-7Search in Google Scholar
Longo F, Hastier P, Buckley MJM, et al. Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone. Am J Gastroenterol 1998;93:836-7.10.1111/j.1572-0241.1998.239_a.x9625142Search in Google Scholar
Maraspin V, Lotric-Furlan S, Strle F. Ceftriaxone- associated hemolysis. Wien Klin Wochenschr 1999;111(9):368-70.Search in Google Scholar
Meyer O, Hackstein H, Hoppe B,et al. Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 1999;105:1084-5.10.1046/j.1365-2141.1999.01434.x10554824Search in Google Scholar
Punar M, Özsü H,Eraksoy H,et al.An adult case of fatal hemolysis induced by ceftriaxone. Clin Microbiol Infect 1999;5:585-6.10.1111/j.1469-0691.1999.tb00441.x11851715Search in Google Scholar
Viner Y, Hashkes PJ, Yakubova R,et al. Severe hemolysis induced by ceftriaxone in a child with sickle cell anemia. Pediatr Infect Dis J 2000;19(1): 83-5.10.1097/00006454-200001000-0001910643859Search in Google Scholar
Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26: 1390-4.10.1007/s00134000059811089773Search in Google Scholar
Falezza GC, Piccoli PL, Franchini M, et al. Ceftriaxone-induced hemolysis in an adult (letter). Transfusion 2000;40:1543-5.10.1046/j.1537-2995.2000.40121543.x11134579Search in Google Scholar
Citak A, Garratty G, Ücsel R,et al. Ceftriaxone- induced haemolytic anaemia in a child with no immune deficiency or haematological disease. J Pediatr Child Health 2002;38:209-10.10.1046/j.1440-1754.2002.00778.x12031011Search in Google Scholar
Kim S, Song KS, Kim HO,et al. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine. Yonsei Med J 2002;43:391-4.10.3349/ymj.2002.43.3.39112089751Search in Google Scholar
Arndt P. Practical aspects of investigating drug- induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach. Immunohematology 2002;18:27-32.10.21307/immunohematology-2019-504Search in Google Scholar
Eastlund T,Mulrooney D, Neglia J,et al. Self-limited immune hemolysis in a child after six days of ceftriaxone therapy (abstract). Transfusion 2002; 42(Suppl):96S.Search in Google Scholar
Garratty G, Nance S, Lloyd M,et al. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32:269-71.10.1046/j.1537-2995.1992.32392213813.x1557811Search in Google Scholar
Weitekamp LA, Johnson ST, Fueger JT, et al. Cefotetan-dependent immune hemolytic anemia due to a single antibody reacting with both drug coated and untreated red cells in the presence of drug. Book of Abstracts. ISBT/AABB Joint Congress. Arlington, VA: American Association of Blood Banks 1990:33.Search in Google Scholar
Wojcicki RE, Larson CJ, Pope ME,et al. Acute hemolytic anemia during cefotetan therapy. Book of Abstracts. ISBT/AABB Joint Congress. Arlington,VA: American Association of Blood Banks 1990:33.Search in Google Scholar
Gallagher MT, Schergen AK, Sokol-Anderson ML, et al. Severe immune mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion 1992;32:266-8.10.1046/j.1537-2995.1992.32392213812.xSearch in Google Scholar
Ehmann WC. Cephalosporin-induced hemolysis: a case report and review of the literature. Am J Hematol 1992;40:121-5.10.1002/ajh.2830400209Search in Google Scholar
Chenoweth CE, Judd WJ, Steiner EA, et al. Cefotetan-induced immune hemolytic anemia. Clin Infect Dis 1992;15:863-5.10.1093/clind/15.5.863Search in Google Scholar
Wagner BKJ, Heaton AH, Flink JR. Cefotetan disodium-induced hemolytic anemia. Ann Pharmacother 1992;26:199-200.10.1177/106002809202600213Search in Google Scholar
Dhawan M, Kiss JE, DiAddezzio NA,et al. Fatal cefotetan-induced immune hemolysis (abstract). Blood 1993;82:582a.Search in Google Scholar
Eckrich RJ, Fox S, Mallory D. Cefotetan-induced immune hemolytic anemia due to the drugadsorption mechanism. Immunohematology 1994;10:51-4.10.21307/immunohematology-2019-818Search in Google Scholar
Peano GM, Menardi G, Quaranta L,et al.A rapidly fatal case of immune haemolytic anaemia due to cefotetan.Vox Sang 1994;66:84-5.10.1111/j.1423-0410.1994.tb00285.xSearch in Google Scholar
Ogburn JR, Knauss MA,Thapar K,et al. Cefotetan- induced immune hemolytic anemia (IHA) resulting from both drug adsorption and immune complex mechanisms (abstract). Transfusion 1994;34(Suppl):27S.Search in Google Scholar
Mohammed S, Knoll S, vanAmburg A III, et al. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol 1994; 46:369-70.10.1002/ajh.2830460422Search in Google Scholar
Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;9:337-42.10.1016/S0002-9378(99)70443-6Search in Google Scholar
Badon SJ, Cable RG. Hemolysis due to cefotetan (abstract).Transfusion 1999;39(Suppl):42S.Search in Google Scholar
Johnson ST, Fueger JT, Gottschall JL. Cefotetan- dependent antibody cross-reacting with ceftriaxone treated RBCs (abstract). Transfusion 1999; 39(Suppl):81S.Search in Google Scholar
Stroncek D, Proctor JL, Johnson J. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction. Am J Hematol 2000;64:67-70.10.1002/(SICI)1096-8652(200005)64:1<67::AID-AJH12>3.0.CO;2-ZSearch in Google Scholar
Naylor CS, Steele L,Hsi LR,et al. Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery. Am J Obstet Gynecol 2000; 182:1427-8.10.1067/mob.2000.106132Search in Google Scholar
Moes GS, MacPherson BR. Cefotetan-induced hemolytic anemia: a case report and review of the literature. Arch Pathol Lab Med 2000;124(a): 1344-6.10.5858/2000-124-1344-CIHASearch in Google Scholar
Marques MB, Carr KD, Brumfield CG,et al. A pregnant patient with sickle cell disease and cefotetan-induced immune hemolysis. Lab Med 2000;31(10):541-3.10.1309/8YEQ-BJLB-JG10-TYBCSearch in Google Scholar
Ray EK, Warkentin TE, O’Hoski PL,et al. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan. Can J Surg 2000;43:461-2.Search in Google Scholar
Chai L, Pomper GJ, Ross RL,et al. Severe hemolytic anemia and liver damage induced by prophylactic use of cefotetan (abstract). Transfusion 2001;41 (Suppl 1):58S.Search in Google Scholar
Afenyi-Annan AN, Judd WJ. Cefotetan induced immune-mediated hemolysis complicated by thrombocytopenia: alloimmune or thrombotic (abstract)? Transfusion 2002;52(Suppl):46S.Search in Google Scholar
Shammo JM, Calhoun B, Mauer AM,et al. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion 1999;39:838-44.10.1046/j.1537-2995.1999.39080838.xSearch in Google Scholar
Endoh T,Yagihashi A, Sasaki M,et al. Ceftizoxime- induced hemolysis due to immune complexes: case report and the epitope responsible for immune complex-mediated hemolysis. Transfusion 1999;39: 306-9.10.1046/j.1537-2995.1999.39399219289.xSearch in Google Scholar
Calhoun BW, Junsanto T, Donoghue MT, et al. Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms.Transfusion 2001;41:893-7.10.1046/j.1537-2995.2001.41070893.xSearch in Google Scholar
Chambers LA, Donovan LM, Kruskall MS. Ceftazidime-induced hemolysis in a patient with drug-dependent antibodies reactive by immune complex and drug adsorption mechanisms. Am J Clin Pathol 1991;95:393-6.10.1093/ajcp/95.3.393Search in Google Scholar
Fueger JT, Bell JA, Gottschall JL,et al. Ceftazidimedependent antibody reacting with untreated red cells in the presence of drug (abstract). Transfusion 2001;41(Suppl 1):104S.Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239-46.10.1046/j.1537-2995.1999.39111239.xSearch in Google Scholar
Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101-7.10.1007/BF03256184Search in Google Scholar
Bateman ST,Hu E, Lane C,et al. Antibody to ceftriaxone in HIV pediatric patients and potential implications for RBC hemolysis (abstract). Blood 2002;100(11):48b.Search in Google Scholar
Leger RM, Arndt PA,Garratty G.A negative or very weakly positive DAT should not exclude the investigation of drug-induced immune hemolytic anemia. Transfusion 2003;43:1640-1.10.1046/j.1537-2995.2003.00562.xSearch in Google Scholar
Petz LD, Branch DR. Drug-induced immune hemolytic anemia. In: Chaplin H Jr.,ed. Immune hemolytic anemias. New York: Churchill Livingstone, 1985:47-94.Search in Google Scholar
Osbourne SE, Johnson ST, Weitekamp LE,et al. Enhanced detection of drug-dependent antibodies reacting with untreated red blood cells in the presence of drug (abstract). Transfusion 1993; 34(Suppl):20SSearch in Google Scholar
Arndt P, Garratty G. Use of albumin solutions for solubilizing certain drugs can decrease binding of drugs to RBCs (abstract). Transfusion 2002;42 (Suppl):105S.Search in Google Scholar
Arndt PA, Garratty G.Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of “naturally- occurring” anti-cefotetan? (abstract). Transfusion 2001;41(Suppl):24S.Search in Google Scholar
Arndt PA, Leger RM,Garratty G. Reactivity of “last wash” elution controls in investigations of cefotetan antibodies (abstract). Transfusion 1999; 39:(Suppl):47S.Search in Google Scholar
Spath P, Garratty G, Petz LD. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971; 107:860-9.10.4049/jimmunol.107.3.860Search in Google Scholar
Garratty G, Petz LD. Drug-induced immune hemolytic anemia. Am J Med 1975;58:398-407.10.1016/0002-9343(75)90606-3Search in Google Scholar
Branch DR,Sy Siok Hian AL, Petz LD. Mechanism of nonimmunologic adsorption of proteins using cephalothin-coated red cells (abstract). Transfusion 1985;24:415.Search in Google Scholar
Garratty G, Leger R. Red cell membrane proteins (CD55 and CD58) are modified following treatment of RBCs with cephalosporins (abstract). Blood 1995;86:68a.Search in Google Scholar
Sirchia G, Murcuriali F, Ferrone S. Cephalothin- treated normal red cells: a new type of PNH-like cells.Experientia 1968;24:495-6.10.1007/BF02144414Search in Google Scholar
Jamin D,Demers J, Shulman I,et al.An explanation for nonimmunologic adsorption of proteins onto red blood cells. Blood 1986;67:993-6.10.1182/blood.V67.4.993.993Search in Google Scholar
Jamin D, Shulman I,Lam HT,et al. Production of a positive direct antiglobulin test due to Suramin. Arch Pathol Lab Med 1988;112:898-900.Search in Google Scholar
Zeger G, Smith L, McQuiston D,et al. Cisplatin- induced nonimmunologic adsorption of immunoglobulin by red cells.Transfusion 1988; 28:493-5.10.1046/j.1537-2995.1988.28588337345.xSearch in Google Scholar
Getaz EP, Beckley S, Fitzpatrick J,et al. Cisplatin- induced hemolysis. N Engl J Med 1980;302:334-5.10.1056/NEJM198002073020607Search in Google Scholar
Levi JA, Aroney RS, Dalley DN. Haemolytic anaemia after cisplatin treatment. Br Med J (Clin Res Ed) 1981;282:2003-4.10.1136/bmj.282.6281.2003Search in Google Scholar
Nguyen BV, Jaffe N, Lichtiger B. Cisplatin-induced anemia. Cancer Treat Rep 1981; 65:1121.Search in Google Scholar
Cinollo G, Dini G, Franchini E,et al. Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother Pharmacol 1988;21:85-6.10.1007/BF00262747Search in Google Scholar
Weber JC, Couppie P, Maloisel F,et al. Anémie hémolytique au cisdiamino-dichloroplatinum. La Press Médicale 1990;19:526-7.Search in Google Scholar
Marani TM, Trich MB, Armstrong KS, et al. Carboplatin-induced immune hemolytic anemia. Transfusion 1996;36:1016-8.10.1046/j.1537-2995.1996.36111297091748.xSearch in Google Scholar
Desrame J, Broustet H, de Talilly PD, et al. Oxaliplatin-induced haemolytic anaemia. Lancet 1999;354:1179-80.10.1016/S0140-6736(99)03827-1Search in Google Scholar
Garufi C, Vaglio S, Brienza S,et al. Immuno- hemolytic anemia following oxaliplatin administration (letter). Ann Oncol 2000;11:497.10.1023/A:1008336108007Search in Google Scholar
Earle CC, Chen WY, Ryan DP et al. Oxaliplatin- induced Evan’s syndrome (letter). Br J Cancer 2001;84:441.10.1054/bjoc.2000.1608236374111161414Search in Google Scholar
Sørbye H, Bruserud Ø, Dahl O. Oxaliplatin- induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol 2001;40:882-3.10.1080/02841860152703553Search in Google Scholar
Arndt P, Garratty G. Positive direct antiglobulin tests associated with oxaliplatin can be caused by antibody and/or nonimmunological protein adsorption (abstract). Transfusion 2003 43:102a.Search in Google Scholar
Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+DAT) in patients receiving Unasyn® (abstract). Transfusion 1992; 32(Suppl):23S.Search in Google Scholar
Garratty G,Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777-83.10.1046/j.1365-2141.1998.00615.xSearch in Google Scholar
Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells (letter). Vox Sang 2003;85:53.10.1046/j.1423-0410.2003.00323.xSearch in Google Scholar
Broadberry RE, Farren TW, Kohler JA, et al. Tazobactum-induced haemolytic anaemia possibly caused by non-immunological adsorption of IgG onto patient’s red cells. Transfus Med 2004; 14:53-7.10.1111/j.0958-7578.2004.00481.xSearch in Google Scholar
Garratty G. Target antigens for red-cell-bound autoantibodies. In: Nance SJ, ed. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks, 1991:33-72.Search in Google Scholar
Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139-43.10.1111/j.1365-2141.1985.tb04069.xSearch in Google Scholar
Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites.Transfus Med Rev 1990;4:69-77.10.1016/S0887-7963(90)70249-0Search in Google Scholar
Shulman NR, Reid DM. Mechanisms of drug- induced immunologically mediated cytopenias. Transfus Med Rev 1993;VII:215-29.10.1016/S0887-7963(93)70142-XSearch in Google Scholar
